Urinary Concentration After Salmeterol

NARecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Healthy
Interventions
OTHER

Normal conditions

Participants are administered salmeterol, after which they perform various performance tests in normal conditions. Following the administration of salmeterol, urine samples are collected over the next 24 hours at intervals of 0.5, 1, 2, 4, 8, and 24 hours after administration.

OTHER

Heated conditions

Participants are administered salmeterol, after which they perform various performance tests in heated conditions. Following the administration of salmeterol, urine samples are collected over the next 24 hours at intervals of 0.5, 1, 2, 4, 8, and 24 hours after administration.

DRUG

Salmeterol inhalation and urine samples

After the experimental day under normal conditions, all participants are administered 200 µg of salmeterol daily (8 puffs from the MDI device) during a 6-day intervention period. Two hours after inhalation, the participants collect spot urine samples at home

Trial Locations (1)

2100

RECRUITING

August Krogh Building, Copenhagen

All Listed Sponsors
lead

University of Copenhagen

OTHER